Journal
PHARMACOGENETICS AND GENOMICS
Volume 24, Issue 2, Pages 133-138Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FPC.0000000000000019
Keywords
cancer; ifosfamide; pathways; pharmacodynamics; pharmacogenomics; pharmacokinetics
Funding
- National Institutes of Health/National Institute of General Medical Sciences [R24 GM61374]